You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 162 No. 18, October 14, 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (57)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Preservation of Cognitive Function With Antihypertensive Medications

A Longitudinal Analysis of a Community-Based Sample of African Americans

Michael D. Murray, PharmD, MPH; Kathleen A. Lane, MS; Sujuan Gao, PhD; Rebecca M. Evans, MD; Frederick W. Unverzagt, MD; Kathleen S. Hall, PhD; Hugh Hendrie, MB, ChB

Arch Intern Med. 2002;162:2090-2096.

Background  Results of previous studies of white older adults suggest that antihypertensive medications preserve cognition. We assessed the long-term effect of antihypertensive medications on cognitive function in a community sample of African American older adults.

Methods  We conducted longitudinal surveys and clinical assessment of cognitive function in a random sample of 2212 community-dwelling African Americans 65 years and older. We identified 1900 participants without evidence of cognitive impairment at baseline, 1617 of whom had subsequent follow-up information, and 946 of whom had blood pressure measurements. Cognitive function was measured at baseline and at 2 and 5 years by means of scores on the Community Screening Instrument for Dementia and neuropsychological and clinical assessment for dementia and cognitive impairment. Prescription and nonprescription medication use was derived from in-home inspection of medications and participant and informant reports.

Results  Of 1900 participants, 288 (15.2%) developed incident cognitive impairment. Using logistic regression to control for the effects of age, sex, education, baseline cognitive scores, and hypertension and angina or myocardial infarction, we found that antihypertensive medications reduced the odds of incident cognitive impairment by 38% (odds ratio, 0.62; 95% confidence interval, 0.45-0.84). Corresponding analysis using blood pressure measurements on the subset of participants was inconclusive.

Conclusion  Antihypertensive medication use is associated with preservation of cognitive function in older African American adults.


From the Departments of Psychiatry (Drs Evans, Unverzagt, Hall, and Hendrie) and Medicine (Drs Murray and Gao and Ms Lane), Indiana University School of Medicine, Department of Pharmacy Practice, Purdue University School of Pharmacy (Dr Murray), and Regenstrief Institute for Health Care (Drs Murray and Hendrie), Indianapolis, Ind.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Review: Blood pressure and dementia -- a comprehensive review
Kennelly et al.
Therapeutic Advances in Neurological Disorders 2009;2:241-260.
ABSTRACT  

Continuity of Health Care and the Pharmacist: Let's Keep It Simple
(Mick) Murray
The Annals of Pharmacotherapy 2009;43:745-747.
ABSTRACT | FULL TEXT  

Racial/Ethnic Disparities in Medication Use Among Veterans with Hypertension and Dementia: A National Cohort Study
Poon et al.
The Annals of Pharmacotherapy 2009;43:185-193.
ABSTRACT | FULL TEXT  

Mild Cognitive Dysfunction: An Epidemiological Perspective With an Emphasis on African Americans
Unverzagt et al.
J Geriatr Psychiatry Neurol 2007;20:215-226.
ABSTRACT  

Dementia and Comorbidities: An Overview of Diagnosis and Management
Swanson and Carnahan
Journal of Pharmacy Practice 2007;20:296-317.
ABSTRACT  

Less Atherosclerosis and Lower Blood Pressure for a Meaningful Life Perspective With More Brain
Staessen et al.
Hypertension 2007;49:389-400.
FULL TEXT  

Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology
Burns and O'Brien
J Psychopharmacol 2006;20:732-755.
ABSTRACT  

Antihypertensive Medication Use and Incident Alzheimer Disease: The Cache County Study
Khachaturian et al.
Arch Neurol 2006;63:686-692.
ABSTRACT | FULL TEXT  

Preventing dementia
Purandare et al.
Adv. Psychiatr. Treat. 2005;11:176-183.
ABSTRACT | FULL TEXT  

Nonlinear Relations of Blood Pressure to Cognitive Function: The Baltimore Longitudinal Study of Aging
Waldstein et al.
Hypertension 2005;45:374-379.
ABSTRACT | FULL TEXT  

Cross-Sectional and Longitudinal Association Between Antihypertensive Medications and Cognitive Impairment in an Elderly Population
Hajjar et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2005;60:67-73.
ABSTRACT | FULL TEXT  

Mixed Dementia: Emerging Concepts and Therapeutic Implications
Langa et al.
JAMA 2004;292:2901-2908.
ABSTRACT | FULL TEXT  

Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function
van Exel et al.
Neurology 2003;61:1695-1701.
ABSTRACT | FULL TEXT  

Blood Pressure and Cognitive Impairment in India and the United States: A Cross-National Epidemiological Study
Pandav et al.
Arch Neurol 2003;60:1123-1128.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.